Cover Image
Market Research Report
Product code 
997033

Global Autoinjectors Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Autoinjectors Market 2021-2025
Published: March 12, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Technavio has been monitoring the autoinjectors market and it is poised to grow by $ 82.91 bn during 2021-2025 progressing at a CAGR of 24% during the forecast period. Our report on autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies and need for immediate care and growing popularity of injectable therapies. In addition, increasing prevalence of allergies and need for immediate care is anticipated to boost the growth of the market as well.

The autoinjectors market analysis includes application segment and geographical landscapes.

Technavio's autoinjectors market is segmented as below:

By Application

  • Anaphylaxis
  • Multiple sclerosis
  • Rheumatoid arthritis
  • Others

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rise in commercial approvals of new products as one of the prime reasons driving the autoinjectors market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on autoinjectors market covers the following areas:

  • Autoinjectors market sizing
  • Autoinjectors market forecast
  • Autoinjectors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoinjectors market vendors that include Amgen Inc., Antares Pharma Inc., Bayer AG, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG. Also, the autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR70391

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Anaphylaxis - Market size and forecast 2020-2025
  • Multiple sclerosis - Market size and forecast 2020-2025
  • Rheumatoid arthritis - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Application

Market Segmentation by End-user

  • Hospitals and clinics
  • Self-administration

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Impact of COVID-19 pandemic and recovery in the global market
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Ypsomed Holding AG

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ billion)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Application - Market share 2020-2025 (%)
  • 22: Comparison by Application
  • 23: Anaphylaxis - Market size and forecast 2020-2025 ($ billion)
  • 24: Anaphylaxis - Year-over-year growth 2020-2025 (%)
  • 25: Multiple sclerosis - Market size and forecast 2020-2025 ($ billion)
  • 26: Multiple sclerosis - Year-over-year growth 2020-2025 (%)
  • 27: Rheumatoid arthritis - Market size and forecast 2020-2025 ($ billion)
  • 28: Rheumatoid arthritis - Year-over-year growth 2020-2025 (%)
  • 29: Others - Market size and forecast 2020-2025 ($ billion)
  • 30: Others - Year-over-year growth 2020-2025 (%)
  • 31: Market opportunity by Application
  • 32: Customer landscape
  • 33: Market share by geography 2020-2025 (%)
  • 34: Geographic comparison
  • 35: North America - Market size and forecast 2020-2025 ($ billion)
  • 36: North America - Year-over-year growth 2020-2025 (%)
  • 37: Europe - Market size and forecast 2020-2025 ($ billion)
  • 38: Europe - Year-over-year growth 2020-2025 (%)
  • 39: Asia - Market size and forecast 2020-2025 ($ billion)
  • 40: Asia - Year-over-year growth 2020-2025 (%)
  • 41: ROW - Market size and forecast 2020-2025 ($ billion)
  • 42: ROW - Year-over-year growth 2020-2025 (%)
  • 43: Key leading countries
  • 44: Market opportunity by geography ($ billion)
  • 45: Impact of drivers and challenges
  • 46: Vendor landscape
  • 47: Landscape disruption
  • 48: Industry risks
  • 49: Vendors covered
  • 50: Market positioning of vendors
  • 51: Amgen Inc. - Overview
  • 52: Amgen Inc. - Business segments
  • 53: Amgen Inc. - Key offerings
  • 54: Amgen Inc. - Key customers
  • 55: Amgen Inc. - Segment focus
  • 56: Antares Pharma Inc. - Overview
  • 57: Antares Pharma Inc. - Business segments
  • 58: Antares Pharma Inc. - Key offerings
  • 59: Antares Pharma Inc. - Key customers
  • 60: Antares Pharma Inc. - Segment focus
  • 61: Bayer AG - Overview
  • 62: Bayer AG - Business segments
  • 63: Bayer AG - Key offerings
  • 64: Bayer AG - Key customers
  • 65: Bayer AG - Segment focus
  • 66: Becton, Dickinson and Co. - Overview
  • 67: Becton, Dickinson and Co. - Business segments
  • 68: Becton, Dickinson and Co. - Key offerings
  • 69: Becton, Dickinson and Co. - Key customers
  • 70: Becton, Dickinson and Co. - Segment focus
  • 71: Eli Lilly and Co. - Overview
  • 72: Eli Lilly and Co. - Business segments
  • 73: Eli Lilly and Co. - Key offerings
  • 74: Eli Lilly and Co. - Key customers
  • 75: Eli Lilly and Co. - Segment focus
  • 76: GlaxoSmithKline Plc - Overview
  • 77: GlaxoSmithKline Plc - Business segments
  • 78: GlaxoSmithKline Plc - Key offerings
  • 79: GlaxoSmithKline Plc - Key customers
  • 80: GlaxoSmithKline Plc - Segment focus
  • 81: Johnson & Johnson - Overview
  • 82: Johnson & Johnson - Business segments
  • 83: Johnson & Johnson - Key offerings
  • 84: Johnson & Johnson - Key customers
  • 85: Johnson & Johnson - Segment focus
  • 86: Teva Pharmaceutical Industries Ltd. - Overview
  • 87: Teva Pharmaceutical Industries Ltd. - Business segments
  • 88: Teva Pharmaceutical Industries Ltd. - Key offerings
  • 89: Teva Pharmaceutical Industries Ltd. - Key customers
  • 90: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 91: Viatris Inc. - Overview
  • 92: Viatris Inc. - Business segments
  • 93: Viatris Inc. - Key offerings
  • 94: Viatris Inc. - Key customers
  • 95: Viatris Inc. - Segment focus
  • 96: Ypsomed Holding AG - Overview
  • 97: Ypsomed Holding AG - Business segments
  • 98: Ypsomed Holding AG - Key offerings
  • 99: Ypsomed Holding AG - Key customers
  • 100: Ypsomed Holding AG - Segment focus
  • 101: Currency conversion rates for US$
  • 102: Research Methodology
  • 103: Validation techniques employed for market sizing
  • 104: Information sources
  • 105: List of abbreviations